Figure 4

Confocal microscopy of CNV lesions. The fluorescent images of CNV in RPE-choroid-sclera flat mounts from the Control (A), CNV (B), CNV with bevacizumab (C), and CNV with HB01 (D) groups were shown. The vasculature was labeled with FITC-dextran via cardiac perfusion on Day 28. The total sizes of neovascular areas for eyes from CNV, CNV with bevacizumab, and CNV with HB01 were summarized in (E). *P < 0.01, Mann Whitney test; NS, not significant.